OptimizeRx Corporation

NASDAQ: OPRX · Real-Time Price · USD
14.65
0.47 (3.31%)
At close: Jun 06, 2025, 3:59 PM
14.56
-0.61%
Pre-market: Jun 09, 2025, 04:00 AM EDT

Company Description

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients.

The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages.

It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products.

In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance.

Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys.

Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations.

It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs.

The company was found in 2006 and is headquartered in Rochester, Michigan.

OptimizeRx Corporation
OptimizeRx Corporation logo
Country United States
IPO Date Nov 28, 2007
Industry Medical - Healthcare Information Services
Sector Healthcare
Employees 128
CEO Stephen L. Silvestro

Contact Details

Address:
400 Water Street
Waltham, Michigan
United States
Website https://www.optimizerx.com

Stock Details

Ticker Symbol OPRX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001448431
CUSIP Number 68401U204
ISIN Number US68401U2042
Employer ID 26-1265381
SIC Code 7389

Key Executives

Name Position
Stephen L. Silvestro President & Chief Executive Officer
Dr. Doug Besch Chief Product Officer & Chief Technology Officer
Edward Stelmakh C.M.A., M.B.A. Chief Financial Officer & Chief Operating Officer
Marion K Odence-Ford Chief Legal Officer & Chief Human Resources Officer
Andrew Jacob D'Silva Senior Vice President of Corporate Finance
Heather Favazza Controller
Maira Alejandra Media Relations Manager
Sheryl Kearney Human Resources Manager
Theresa Greco Chief Commercial Officer

Latest SEC Filings

Date Type Title
May 19, 2025 4 Filing
May 19, 2025 4 Filing
May 13, 2025 10-Q Quarterly Report
May 12, 2025 8-K Current Report
Apr 30, 2025 SCHEDULE 13G/A [Amend] Filing
Apr 30, 2025 ARS Filing
Apr 30, 2025 DEF 14A Filing
Apr 21, 2025 SCHEDULE 13D/A [Amend] Filing
Apr 18, 2025 8-K Current Report
Mar 28, 2025 S-3 Filing